Kura Oncology Inc. (NASDAQ:KURA) shares rose 6.7% during mid-day trading on Tuesday . The stock traded as high as $5.76 and last traded at $5.70, with a volume of 57,780 shares. The stock had previously closed at $5.34.

KURA has been the subject of several analyst reports. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $16.00 price target on shares of Kura Oncology in a report on Tuesday, June 21st. Zacks Investment Research cut shares of Kura Oncology from a “buy” rating to a “hold” rating in a report on Tuesday, May 17th.

The stock’s 50-day moving average price is $4.68 and its 200 day moving average price is $3.75. The company’s market capitalization is $108.15 million.

Kura Oncology (NASDAQ:KURA) last announced its quarterly earnings data on Wednesday, August 10th. The company reported ($0.36) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.34) by $0.02. Equities analysts anticipate that Kura Oncology Inc. will post ($1.58) EPS for the current year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.